How we read a label.

Why SharpAndLean exists

Supplement shopping has a peculiar problem: the loudest claim is often the easiest thing to find, while the information needed to judge it is scattered across a label, a manufacturer’s website and research that may not even test the finished product. SharpAndLean was created to close that gap. The aim is practical: help a reader understand what is in a formula, whether the amount is disclosed, what the research can actually support and where the uncertainty begins.

That means resisting the rhythm of the typical affiliate page. A long ingredient list is not proof of a better product. “Clinically studied” is not useful when the study used a different extract or a dose several times larger than the one on the label. A polished certificate image is not the same as a batch-specific report from an independent laboratory. These distinctions are small on the page and enormous when somebody is deciding what to swallow every day.

SharpAndLean is published independently and is not owned by, or operated on behalf of, any supplement brand or parent company. Sumita Bhatti, a clinical nutritionist with more than 15 years of experience, leads the review perspective. Her role is to keep the analysis grounded in nutrition practice: check the dose, read beyond the abstract, account for interactions and say plainly when a claim runs ahead of the evidence.

How a review is produced

Every assessment starts with the current Supplement Facts panel and the manufacturer’s directions. We record the serving size, each disclosed dose, proprietary blends, stimulant sources, allergen statements, price and refund terms. We then separate three questions that marketing often blends together: is there evidence for the ingredient, is the form and dose comparable to that evidence, and has the finished formula itself been tested?

Research quality matters. A randomized controlled trial generally tells us more about efficacy than a cell experiment, but one short trial with a small sample does not settle a question. We look for systematic reviews, replication, clinically meaningful outcomes and a population that resembles the people likely to use the product. Surrogate outcomes are labelled as such. Animal and laboratory findings can explain a possible mechanism; they do not prove a consumer benefit.

Quality claims receive their own check. “Made in an FDA-registered facility” does not mean FDA approved the supplement. A testing claim is strongest when the company provides a recent, batch-linked certificate showing the laboratory, methods and results. Certifications are checked against the certifier’s own directory where one exists. Missing evidence is recorded as missing. We do not fill the gap with assumptions.

Why some brands appear more often

This method depends on a manufacturer publishing a complete, checkable Supplement Facts panel. Some companies do; others put a marketing page where the panel should be, hide the label behind a retailer listing, or block access to their own product pages altogether. Coverage therefore skews toward brands whose labels can actually be verified, and that is a property of our sourcing rather than a verdict on the companies missing from it. Appearing here often is not an endorsement, and being absent is not a criticism.

Who signs which page

Two bylines appear on this site and they mean different things. A page signed by the SNL Team is a label overview: the editorial desk has transcribed the Supplement Facts panel from the manufacturer’s own published page, done the serving arithmetic and checked the claim against the research for that ingredient. It is a record of what a label says.

A page signed by Sumita Bhatti carries a clinical nutritionist’s reading of the evidence. That is a different kind of judgement and it is attributed to a named person who can be looked up. We keep the two apart deliberately: a label transcription does not borrow clinical authority it has not earned, and a clinical view is not published anonymously.

What can disqualify a product

An undisclosed proprietary blend can prevent a positive assessment when dose is central to the claim. Other serious problems include hidden stimulant totals, disease-treatment language, a testing claim that cannot be verified, a label that conflicts with the sales page, or a dose far below the range used in the cited research. Safety concerns carry more weight than novelty, packaging or the size of an affiliate commission.

Scores are editorial conclusions, not laboratory results. The written reasoning matters more than the number. A product can use familiar ingredients and still earn a weak assessment because the doses are concealed or the evidence does not match the promise. It can also be competently formulated without being necessary for most readers.

Editorial independence

SharpAndLean does not sell rankings, accept payment for a positive verdict or allow a brand to approve a review before publication. A company may correct a factual detail and may provide supporting documents. It cannot negotiate the conclusion. Products available through Amazon, ClickBank, Awin or Gurumedia may generate a commission when a reader uses a clearly marked affiliate link. That commercial relationship is kept separate from the assessment.

We will not invent a negative affiliate-partner example to perform independence. When a real reviewed product qualifies, the review itself will show the evidence, relationship and verdict. Until then, the honest statement is the narrower one: affiliate availability never guarantees inclusion, placement or a favourable score.

What we do not do

• No pay-for-placement or sponsored rankings.
• No diagnosis, treatment plans or promises that a supplement can cure disease.
• No borrowed score based on customer reviews alone.
• No citation added merely because it mentions an ingredient; the form, dose, population and outcome must be relevant.
• No quiet rewriting of a material conclusion. Substantive updates should carry a visible date and explanation.

Corrections and updates

Published reviews are checked when a brand changes its label and during scheduled editorial reviews. High-interest pages receive the earliest attention. Readers and brands can report an error through the contact page. We verify the primary source, correct factual mistakes promptly and update the review date. A disagreement with an editorial judgment is considered, but it is not automatically a factual error.

Research changes too. A new trial may strengthen a claim, weaken it or expose a safety issue. Reviews are living documents, and an old date is a reason to recheck the evidence rather than pretend the page is timeless.

How the site is funded

Some outbound purchase links are affiliate links. If a reader buys through one, SharpAndLean may receive a commission without adding a separate charge to the reader. SharpAndLean participates in the Amazon Associates Program, ClickBank, Awin and Gurumedia. Availability varies by product, and many links earn nothing at all. Read the full affiliate disclosure for the practical details.